Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine von Nahas, Myrna R., Stroopinsky, Dina, Rosenblatt, Jacalyn, Cole, Leandra, Pyzer, Athalia R., Anastasiadou, Eleni, Sergeeva, Anna, Ephraim, Adam, Washington, Abigail, Orr, Shira, McMasters, Malgorzata, Weinstock, Matthew, Jain, Salvia, Leaf, Rebecca K., Ghiasuddin, Haider, Rahimian, Maryam, Liegel, Jessica, Molldrem, Jeffrey J., Slack, Frank, Kufe, Donald, Avigan, David

Volltext

Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study von Ghione, Paola, Palomba, M Lia, Ghesquieres, Hervé, Bobillo, Sabela, Patel, Anik R, Nahas, Myrna, Kanters, Steve, Deighton, Kevin, Hatswell, Anthony, Ma, Long, Limbrick-Oldfield, Eve H, Snider, Julia Thornton, Wade, Sally W, Riberio, Maria Teresa, Radford, John, Beygi, Sara, Gribben, John

Volltext

Anti-cancer vaccine therapy for hematologic malignancies: An evolving era von Nahas, Myrna R., Rosenblatt, Jacalyn, Lazarus, Hillard M., Avigan, David

Volltext

Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model von Stroopinsky, Dina, Liegel, Jessica, Bhasin, Manoj, Cheloni, Giulia, Thomas, Beena, Bhasin, Swati, Panchal, Ruchit, Ghiasuddin, Haider, Rahimian, Maryam, Nahas, Myrna, Orr, Shira, Capelletti, Marzia, Torres, Daniela, Tacettin, Cansu, Weinstock, Matthew, Bisharat, Lina, Morin, Adam, Mahoney, Kathleen M, Ebert, Benjamin, Stone, Richard, Kufe, Donald, Freeman, Gordon J, Rosenblatt, Jacalyn, Avigan, David

Volltext

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease von Nahas, Myrna R., Soiffer, Robert J., Kim, Haesook T., Alyea, Edwin P., Arnason, Jon, Joyce, Robin, Antin, Joseph H., Ho, Vincent T., Stroopinsky, Dina, Li, Shuli, Levine, James D., McMasters, Malgorzata, Jain, Salvia, Hamdan, Ayad, Tzachanis, Dimitrios, Bryant, Mary Paty, Logan, Emma K., Bazemore, Josie, Stewart, Jeremy, Joyce, Amy, Stephenson, Susan, Washington, Abigail, Cole, Leandra, Pyzer, Athalia, Leaf, Rebecca Karp, Avigan, David E., Rosenblatt, Jacalyn

Volltext

Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1 von Bar‐Natan, Michal, Stroopinsky, Dina, Luptakova, Katarina, Coll, Maxwell D., Apel, Arie, Rajabi, Hasan, Pyzer, Athalia R., Palmer, Kristen, Reagan, Michaela R., Nahas, Myrna R., Karp Leaf, Rebecca, Jain, Salvia, Arnason, Jon, Ghobrial, Irene M., Anderson, Kenneth C., Kufe, Donald, Rosenblatt, Jacalyn, Avigan, David

Volltext

Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma von Jain, Salvia, Washington, Abigail, Leaf, Rebecca Karp, Bhargava, Parul, Clark, Rachael A, Kupper, Thomas S, Stroopinsky, Dina, Pyzer, Athalia, Cole, Leandra, Nahas, Myrna, Apel, Arie, Rosenblatt, Jacalyn, Arnason, Jon, Kufe, Donald, Avigan, David

Volltext

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma von Leaf, Rebecca Karp, Stroopinsky, Dina, Pyzer, Athalia R, Kruisbeek, Ada M, van Wetering, Sandra, Washington, Abigail, Ephraim, Adam, Cole, Leandra, Morin, Adam, Jain, Salvia, Nahas, Myrna R, Apel, Arik, Arnason, Jon, Hamdan, Ayad, Rosenblatt, Jacalyn, Avigan, David

Volltext

Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance von Miller, David M., Drews, Reed E., Nahas, Myrna R., Shalhout, Sophia Z.

Volltext

P1107: ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA von Flinn, Ian W., Jacobson, Caron, Nastoupil, Loretta J., Morschhauser, Franck, Davies, Andrew J., Buske, Christian, Corradini, Paolo, Lopez‐Guillermo, Armando, Reshef, Ran, Parameswaran, Vinod, Sehgal, Alison, Tees, Michael, Lui, Christine, Xue, Wei, Beygi, Sara, Grechko, Nikolay, Bolsue, Pisita, Giovanetti, Alessandro, To, Christina, Nahas, Myrna

Volltext

Targeting CD20 in chronic lymphocytic leukemia von Arnason, Jon, Nahas, Myrna

Volltext

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia von Pyzer, Athalia Rachel, Stroopinsky, Dina, Rajabi, Hasan, Washington, Abigail, Tagde, Ashujit, Coll, Maxwell, Fung, Jacqueline, Bryant, Mary Paty, Cole, Leandra, Palmer, Kristen, Somaiya, Poorvi, Karp Leaf, Rebecca, Nahas, Myrna, Apel, Arie, Jain, Salvia, McMasters, Malgorzata, Mendez, Lourdes, Levine, James, Joyce, Robin, Arnason, Jon, Pandolfi, Pier Paolo, Kufe, Donald, Rosenblatt, Jacalyn, Avigan, David

Volltext

Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma von Ghione, Paola, Palomba, M. Lia, Patel, Anik R., Bobillo, Sabela, Deighton, Kevin, Jacobson, Caron A., Nahas, Myrna, Hatswell, Anthony J., Jung, A. Scott, Kanters, Steve, Snider, Julia Thornton, Neelapu, Sattva S., Ribeiro, Maria Teresa, Brookhart, M. Alan, Ghesquieres, Herve, Radford, John, Gribben, John G.

Volltext

KITE-363: A phase 1 study of an autologous anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory (R/R) B-cell lymphoma (BCL) von Nastoupil, Loretta J., Dahiya, Saurabh, Miklos, David Bernard, Reagan, Patrick Michael, Ulrickson, Matthew, Jung, A. Scott, Kloos, Ioana, Dong, Jinghui, Chou, Justin, Murakami, Jodi, Rodriguez, Katherine, Nahas, Myrna

Volltext

A 3-Year Follow-up Comparison of Clinical Outcomes from Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular L... von Ghione, Paola, Palomba, Maria Lia, Ray, Markqayne D., Limbrick-Oldfield, Eve H., Owen, Jess, Kanters, Steve, Bobillo, Sabela, Ribeiro, Maria Teresa, Jacobson, Caron A., Neelapu, Sattva S., Ghesquieres, Herve, Nahas, Myrna, Beygi, Sara, Patel, Anik R., Gribben, John G.

Volltext

ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma von Oluwole, Olalekan O., Kenderian, Saad S., Shiraz, Parveen, Karmali, Reem, Reshef, Ran, McCarthy, Philip L., Ghosh, Nilanjan, Lazaryan, Aleksandr, Filosto, Simone, Poddar, Soumya, Mao, Daqin, Peng, Andrew, Kilcoyne, Adrian, Nahas, Myrna, Neelapu, Sattva S.

Volltext

ZUMA-19: A Phase 1/2 Multicenter Study of Lenzilumab Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) With Relapsed or Refractory Large B Cell Lymphoma (R/R LBCL) von Kenderian, Saad S., Oluwole, Olalekan O., McCarthy, Philip L., Reshef, Ran, Shiraz, Parveen, Ahmed, Omar, Le Gall, John, Nahas, Myrna, Tang, Lily, Neelapu, Sattva S.

Volltext

Treatment with DC/AML Fusion Vaccine and CD3xCD123 Bi-Specific T-Cell Engager (CD123-CODV-TCE) for Treatment of Acute Myeloid Leukemia von Stroopinsky, Dina, Koshy, Anita G., Liegel, Jessica J., Nahas, Myrna, Cheloni, Giulia, Hauser, Joshua, Torres, Daniela, Bindal, Poorva, Rahimian, Maryam, Bisharat, Lina, Fraenkel, Paula, Yildirim, Ozlem, Bonnevaux, Helene, Guerif, Stephane, Kufe, Donald, Rosenblatt, Jacalyn, Avigan, David

Volltext

ZUMA-22: A phase 3, randomized controlled study of axicabtagene ciloleucel (axi-cel) versus standard-of-care therapy in patients with relapsed or refractory (R/R) follicular lympho... von Flinn, Ian W., Jacobson, Caron Alyce, Nastoupil, Loretta J., Morschhauser, Franck, Davies, Andrew, Buske, Christian, Corradini, Paolo, López Guillermo, Armando, Reshef, Ran, Parameswaran, Vinod, Sehgal, Alison, Tees, Michael Timothy, Lui, Christine, Xue, Wei, Beygi, Sara, Grechko, Nikolay, Bolsue, Pisita, Giovanetti, Alessandro, To, Christina Ann, Nahas, Myrna

Volltext

CD155-Tigit Pathway Modulation in Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine Model von Nahas, Myrna, Stroopinsky, Dina, Capelletti, Marzia, Rosenblatt, Jacalyn, Orr, Shira, Ghiasuddin, Haider, Morin, Adam, Liegel, Jessica, Kufe, Donald, Avigan, David E.

Volltext